Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10802459 | 1.00 | KMT2A (0.46) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL5352569 | 1.00 | KMT2A (0.46) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL5352566 | 1.00 | KMT2A (0.46) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL8447872 | 0.96 | KMT2A (0.50) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL8052321 | 0.96 | KMT2A (0.50) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL11103795 | 0.92 | KMT2A (0.46) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL11103787 | 0.92 | KMT2A (0.46) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL7511856 | 0.91 | HTT (0.43) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL8380862 | 0.91 | HTT (0.43) | KMT2AHTTSMN1; SMN2TDP1F2 | |
| SCHEMBL8035948 | 0.91 | HTT (0.43) | KMT2AHTTSMN1; SMN2TDP1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8425988-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer | JNC CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8425988-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer | JNC CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20110147656-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS HAVING OXIRANYL GROUP, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS AND POLYMERS | CHISSO CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110147657-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC POLYMER | CHISSO CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
| US-7749403-B2 | Monofluorinated terphenyl compound having alkenyl, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| EP-0306917-B1 | A NEMATIC LIQUID CRYSTAL COMPOSITION | CHISSO CORPORATION (JP) | 1992-06-17 | — | — | EP | disclosed |
| US-5122295-A | Containing liquid crystal mixture with high resistivity | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-06-16 | — | — | US | disclosed |
| US-5102577-A | Supertwisted birefringence system | CHISSO CORPORATION (JP) | 1992-04-07 | — | — | US | disclosed |
| EP-0281065-B1 | LIQUID CRYSTAL COMPOSITION AND DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1991-11-27 | — | — | EP | disclosed |
| EP-0393636-A2 | Liquid crystal composition and liquid crystal display using said composition | CHISSO CORPORATION (JP) | 1990-10-24 | — | — | EP | disclosed |
| US-4917818-A | STEEP VOLTAGE TRANSMITTANCE USED IN WATCHES, ELECTRONIC CALCULATORS | CHISSO CORPORATION (JP) | 1990-04-17 | — | — | US | disclosed |
| US-4877549-A | HIGH MULTIPLEXING DISPLAY DEVICE | CHISSO CORPORATION (JP) | 1989-10-31 | — | — | US | disclosed |
| EP-0318003-A2 | A liquid crystal composition for twist nematic mode | CHISSO CORPORATION (JP) | 1989-05-31 | — | — | EP | disclosed |
| EP-0306917-A2 | A nematic liquid crystal composition | CHISSO CORPORATION (JP) | 1989-03-15 | — | — | EP | disclosed |
| EP-0281065-A1 | Liquid crystal composition and display element | CHISSO CORPORATION (JP) | 1988-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CCNT1, POF1B, CCND3 | KMT2A 2708/4885HTT 3389/4885SMN1; SMN2 3851/4885 |
| US-20110147657-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC POLYMER | SSB, LEF1, UACA | KMT2A 579/4885HTT 2689/4885SMN1; SMN2 3174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.